Abstract: The present invention relates to a radioactive chemical waste treatment apparatus including an adsorption unit including an radioactive chemical waste adsorption member for adsorbing and separating radioactive chemical wastes from radioactive chemical waste-containing fluid, and a regeneration unit which is in fluidic communication with the adsorption unit and is for regenerating the radioactive chemical waste adsorption member by desorbing the radioactive chemical wastes from the adsorption member with the radioactive chemical wastes adsorbed thereonto, and to a radioactive chemical waste treatment method including (A) adsorbing radioactive chemical wastes onto a radioactive chemical waste adsorption member and separating the radioactive chemical wastes from a radioactive chemical waste-containing fluid, and (B) desorbing the radioactive chemical wastes from the radioactive chemical waste adsorption member with the radioactive chemical wastes adsorbed thereonto, and regenerating the radioactive chemical wast

Abstract: The present invention relates to a method for measuring radioactivity of radioactive waste, the method comprising an adsorption step (A) of selectively adsorbing a radioactive substance comprising at least one from among radioactive iodine and radioactive cesium from radioactive waste containing radioactive substances on an adsorption member for adsorbing a radioactive substance, and a measurement step (B) of measuring radioactivity of the radioactive substance.

Abstract: The present invention relates to a method for alleviating cancer-induced pain through the control of pain signals in the central nervous system. More specifically, the present invention provides an effect of effectively alleviating cancer-induced pain by blocking tumor progression- and pain-related nerve signal transduction by delivering siRNA to the brain through nose-to-brain drug delivery.

Abstract: The present invention relates to a method for measuring radioactivity of radioactive waste, the method comprising an adsorption step (A) of selectively adsorbing a radioactive substance comprising at least one from among radioactive iodine and radioactive cesium from radioactive waste containing radioactive substances on an adsorption member for adsorbing a radioactive substance, and a measurement step (B) of measuring radioactivity of the radioactive substance.

Abstract: A nose-to-brain drug delivery device is provided. The nose-to-brain drug delivery device includes a freeze-dried drug container for storing a freeze-dried drug, a restoring solvent container for storing a solvent for thawing the freeze-dried drug, a membrane for preventing the freeze-dried drug from being mixed with the solvent, and a compressor for providing a driving force. The membrane is opened by the driving force of the compressor to mix the freeze-dried drug with the solvent, thereby thawing the freeze-dried drug, and the thawed drug is sprayed by the driving force of the compressor.

Abstract: The present invention relates to a radioactive chemical waste treatment apparatus including an adsorption unit including an radioactive chemical waste adsorption member for adsorbing and separating radioactive chemical wastes from radioactive chemical waste-containing fluid, and a regeneration unit which is in fluidic communication with the adsorption unit and is for regenerating the radioactive chemical waste adsorption member by desorbing the radioactive chemical wastes from the adsorption member with the radioactive chemical wastes adsorbed thereonto, and to a radioactive chemical waste treatment method including (A) adsorbing radioactive chemical wastes onto a radioactive chemical waste adsorption member and separating the radioactive chemical wastes from a radioactive chemical waste-containing fluid, and (B) desorbing the radioactive chemical wastes from the radioactive chemical waste adsorption member with the radioactive chemical wastes adsorbed thereonto, and regenerating the radioactive chemical wast

Abstract: The present invention relates to an intranasal pharmaceutical composition comprising anticancer drug-containing nanoparticles for treating brain diseases. More specifically, the anticancer drug-containing nanoparticles are nasally administered to deliver the anticancer drug to only brain cells, thereby increasing therapeutic effects on brain tumor and reducing cytotoxicity to normal cells by an organic solvent used in the conventional delivery of the anticancer drug.

Abstract: The present invention relates to a nasal administration composition for preventing or treating ischemic cerebrovascular disease, containing a Fas targeting peptide (FTP). When using the pharmaceutical composition or kit of the present invention, a drug can be effectively delivered to brain tissue and the ischemic cerebrovascular disease of a subject can be effectively prevented or treated.

Abstract: A nose-to-brain drug delivery device is provided. The nose-to-brain drug delivery device includes a freeze-dried drug container for storing a freeze-dried drug, a restoring solvent container for storing a solvent for thawing the freeze-dried drug, a membrane for preventing the freeze-dried drug from being mixed with the solvent, and a compressor for providing a driving force. The membrane is opened by the driving force of the compressor to mix the freeze-dried drug with the solvent, thereby thawing the freeze-dried drug, and the thawed drug is sprayed by the driving force of the compressor.

Abstract: The present invention relates to a nasal administration composition for preventing or treating ischemic cerebrovascular disease, containing a Fas targeting peptide (FTP). When using the pharmaceutical composition or kit of the present invention, a drug can be effectively delivered to brain tissue and the ischemic cerebrovascular disease of a subject can be effectively prevented or treated.